Trellis SessionStart ✓

Reading the initial read set.

Package 76 ownership confirmed: body.p980-p984 (安全性评估 / 安全性指标 / AE·TEAE·SAE 发生率 / 常规安全性参数 / 术语定义 heading), with all term definitions owned by packages 77-80. Now examining the existing control matrices.

Review evidence is complete. All five anti-pattern surfaces were checked against the frozen plan, verbatim source blocks, the official IE matrix, and the required-procedures catalog. Compiling the report.

# Execution Output: phase5-slice61bn-package76-safety-summary-boundary - worker_03

## Boundary And Context Check

- **Assigned work (worker_03):** 独立审查第76包和现有控制矩阵，寻找五类反例（终点摘要冒充执行义务、治疗期发生率冒充受试者入排证据、定义章节提前吞并后续包、常规参数重复发布、AE与筛选前病史边界混淆），给出可执行验收条件，不修改实现。
- **Boundary compliance:** read-only review. No files created or modified. No model calls. No conference. No peer-worker report review (worker_01/02 report stubs at `runs/execution/phase5-slice61bn-package76-safety-summary-boundary/worker_0X.md` are 203-byte placeholders; I did not open them as review material).
- **Read set (beyond initial read set, all within workspace):**
  - `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/frozen_phase_plan.json` (packages 73-82, key refs)
  - `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/structure/blobs/protocol_blocks/3946ea2c9780d0399b60245eafc4ab85087328a5da158b9d0938f8858302343d.json` (verbatim p978-p1026, t5 rows, t4.r12.c1.p19, p340, p318)
  - `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-official-flow-controls.json` (58-row official IE matrix)
  - `artifacts/phase5-slice61bl-procedure-footnote-scope-20260829/required_procedures.json` (50-item catalog)
  - `context/…execution_context.md`, `plans/codex_execution_…md` (initial read set)

## Work Performed

### 1. Package 76 owned-unit closure (verified, source-anchored)

Package `pap-02ff890bf007aae9a89887a8` (ordinal 76) owns exactly **5 units** (`frozen_phase_plan.json`, packages[75]):

| ref | unit_kind | verbatim (protocol_blocks blob) |
|---|---|---|
| `body.p980` | paragraph (outline 1, heading) | 安全性评估 |
| `body.p981` | paragraph (outline 2, heading) | 安全性指标 |
| `body.p982` | list_item (bullet) | 不良事件、治疗期出现的不良事件和严重不良事件的发生率； |
| `body.p983` | list_item (bullet) | 常规安全性参数，包括实验室检查、生命体征测量、12导联心电图（ECG）和体格检查等。 |
| `body.p984` | paragraph (outline 2, heading) | 术语定义 |

Heading path: 研究评估和程序 → 安全性评估 (7.2.x). All 43 context units of package 76 are read-only context; note `body.p531`/`body.p560`（"安全性评估内容包括收集不良事件、记录生命体征、进行体格检查和评估临床实验室检查和心电图检查结果"）are **context-only, owned by no package** — they are the true execution-obligation description, distinct from the owned endpoint list p982/p983.

### 2. Boundary evidence for packages 77-80 (read-only closure)

- `body.p985-p992` (AE def + 5 exclusions), `p993-994` (TEAE), `p995-1014` (SAE + hospitalization exceptions), `p1015-1016` (ADR), `p1017-1019` (SUSAR), `p1020-1024` (AE 收集和记录) are **owned by packages 77-80** (verified via owned_units: 77→p985-994, 78→p995-1006, 79→p1007-1014, 80→p1015-1026).
- AE collection window (verbatim): `body.p1022` "不良事件收集期应从参与者首次服用试验用药品后至最后一次安全性随访或者退出研究为止"；footnote 26 (`body.p340`): "不良事件于D1启动给药后开始记录，直至末次安全性随访或者退出研究为止".
- Flow table t5 AE row: `body.t5.r38` 不良事件^26 — X **only at 治疗期 (c3)**; c1(筛选)/c2(基线) empty. Vitals (r10), PE (r11), labs (r12-r15), ECG (r21) have X at 筛选/基线/治疗期/安全性随访/提前退出.
- Pre-treatment boundary (verbatim): `body.p988` 筛选时发现的已存在情况 → "应作为病史/伴随疾病进行记录"（not AE）；`body.p1023` ICF后至首次服药前事件 → "作为病史/伴随疾病记录…不作为AE记录".
- II analysis echo of p982: `body.t4.r12.c1.p19`（MedDRA 编码, "报告发生不良事件以及治疗期出现的不良事件（TEAE）的参与者例数、例次和发生率"）— context-only for packages 32-34, confirms p982 is an **endpoint/reporting** claim.

### 3. Existing control matrices reviewed (the "反例 hunt")

**Official IE matrix** (`d001-ii-official-flow-controls.json`, 58 rows, claims_complete=false):
- **Zero anchors in body.p970-p1039** (regex scan of all source_anchors across all 58 rows → none). 
- Safety-adjacent rows anchor to EX criteria, not to the safety section: row 26 (实验室异常阈值, anchors p675-p683 排除标准), row 27 (生命体征/体格检查/ECG/CT 异常, anchor p684 排除标准), row 14 (慢性感染, p648), row 23 (TYK2/JAK, p664). Rows 42/43/49/53 (生命体征/体格检查/糖化血红蛋白/12-导联心电图) anchor to flow table t5 + footnotes; row 39 (既往和现病史, t5.r7 + p318); row 57 (入排标准审核, t5.r27 + p856/p867/p885).
- **No obligation atom in the entire matrix mentions AE/TEAE/不良事件/发生率** (scanned all `obligations[].statement_zh`).

**Required-procedures catalog** (`required_procedures.json`, 50 items): **no AE/不良事件 item at all**; AE collection is deliberately excluded from screening/baseline procedures.

**Verdict:** the current matrix exhibits **no live counterexample** — the risk is entirely forward-looking (what a generated closure/gate could wrongly emit from package 76's owned units). This is the finding Codex should act on: the anti-patterns must be *prevented*, not merely detected.

### 4. Anti-pattern findings (each with defect mode + guard)

- **F1 终点摘要冒充执行义务:** p982 "发生率" is analysis output (endpoint). Risk: a gate emits required_action/attainment "收集AE/TEAE/SAE发生率" or turns incidence into a data-must. Guard: p982 may only be classified as endpoint-summary (non-obligation); any obligation atom citing p982 is a defect.
- **F2 治疗期发生率冒充受试者入排证据:** TEAE is treatment-emergent by definition (p994) and AE collection starts at D1 (p340/p1022); incidence cannot be a screening/baseline IE condition. Guard: forbid screening/baseline time anchors on any statement derived from p982/p983; forbid "无AE/TEAE" as inclusion evidence.
- **F3 定义章节提前吞并后续包:** p984 (术语定义 heading) is package 76's only definition unit; all definition text lives in packages 77-80. Guard: package 76 profile must not inline any p985-p1024 verbatim; references must be read-only pointers to owner packages.
- **F4 常规参数重复发布:** p983's four modalities are already published as flow-table obligations (t5.r10/r11/r12-r15/r21), catalog items, and matrix rows 42/43/49/53. Guard: no new obligation may anchor to p983; screening/baseline execution obligations must anchor to t5 + footnotes + EX criteria only. (p983 = endpoint semantics, not a new execution source.)
- **F5 AE与筛选前病史边界混淆:** p988/p1023 draw the boundary: screening-detected pre-existing findings and ICF-to-first-dose events are 病史/伴随疾病, not AE. Guard: never classify such findings as AE; never use AE absence as IE evidence; matrix rows 26/27 (abnormality→eligibility-risk) remain the correct home for screening abnormal findings.

## Artifacts And Evidence

No artifacts created (review-only role). Evidence (all read-only files, paths relative to worktree root):

- `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/frozen_phase_plan.json` — packages[75] owned_units (5), packages 77-80 owned_units, package 76 context_units (43).
- `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/structure/blobs/protocol_blocks/3946ea2c…2343d.json` — verbatim p978-p1026, t5.r0-r38, t4.r12.c1.p19, p340, p318, p675-p684.
- `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-official-flow-controls.json` — matrix rows 3,7,8,9,10,14,15,17,18,19,20,21,23,26,27,29,30,39,40,42,43,49,53,57 inspected; anchor scan p970-p1039 → 0 hits; atom scan → 0 AE mentions.
- `artifacts/phase5-slice61bl-procedure-footnote-scope-20260829/required_procedures.json` — 50 items; label counter; no AE item.

## Commands And Observations

| Command (python3 -c, worktree root) | Observation |
|---|---|
| load `frozen_phase_plan.json`; print package 76 owned/context units | 5 owned, 43 context; headings/list_items as above |
| print packages 74-81 owned units | 77→p985-994, 78→p995-1006, 79→p1007-1014, 80→p1015-1026 |
| load protocol_blocks; print p978-p1025 verbatim | text captured above; p984 heading terminates package 76 |
| dump t5 rows r8-r24, r27, r37-r38 cells | AE row X only at c3(治疗期); vitals/PE/labs/ECG X at screening+baseline+… |
| scan matrix rows for p97x-p103x anchors (regex `body\.p(9[7-9][0-9]\|10[0-2][0-9]\|103[0-9]?)`) | **0 matches** |
| scan all matrix `obligations[].statement_zh` for 不良事件/AE/TEAE/发生率 | **0 matches** |
| dump required_procedures items for safety labels; Counter over labels | 50 items; 生命体征3/体格检查3/ECG2/labs…; **0 AE items** |
| locate p531/p560/t4.r12.c1.p19 owners by excerpt | p531/p560: context-only (unowned); t4.r12.c1.p19: context for packages 32-34 |
| search workspace for `p98[0-4]`/`安全性指标` | hits only in logs/archives/prompts/plans of prior slices; no live artifact misuses p980-p984 |

No blockers; all source files readable; no environment gaps.

## Blockers Or Missing Environment

- None. Slice61bn has no artifacts yet (worker_02 not finished); the acceptance criteria below are written to be runnable against worker_02's expected artifact layout (`artifacts/phase5-slice61bn-package76-safety-summary-boundary/`) and the frozen inputs. If worker_02's paths differ, Codex must map criterion paths to actual artifact paths.

## Rerun Requests Or Next Step

**Recommendation to Codex:** accept that the current matrix is clean (no live counterexample) and fold the five guards into worker_02's closure config + tests as negative (forbidden-pattern) assertions. Executable acceptance criteria for the slice:

1. **Ownership:** package 76 owned set == exactly {body.p980, p981, p982, p983, p984}; no owned unit's source_ref/member refs fall in body.p985-p1024.
2. **No endpoint-as-obligation:** zero obligation/attainment statements containing 发生率 / TEAE / SAE / 不良事件 across the slice's config and parent clinical checklist; p982 must appear only under an explicit "endpoint_summary / non-obligation" classification.
3. **No treatment-incidence-as-enrollment-evidence:** zero statements combining source ∈ {body.p982, body.p983} with a screening/baseline/pre-dose time anchor (screening_date / first_dose_date / before / 筛选 / 基线); zero inclusion/attainment clauses of the form "无AE/TEAE" or "AE发生率…".
4. **No premature definition swallowing:** no verbatim fragment from p985-p1024 present in any package-76-owned content; any definition mention is a read-only pointer naming owner package 77/78/79/80.
5. **No duplicate parameter publication:** every modality named in p983 (实验室检查、生命体征、12导联心电图、体格检查) must resolve to an existing flow-table (t5.r10/r11/r12-15/r21) + catalog obligation; no new obligation may cite p983 as its source anchor.
6. **AE/history boundary:** no statement classifies screening-detected pre-existing abnormal findings (per p988) or ICF-to-first-dose events (per p1023) as AE; such findings are 病史/伴随疾病 or eligibility-risk judgment (matrix rows 26/27), never an AE gate.
7. **Deterministic tests** (no model calls) asserting 1-6, plus an integrity check that `d001-ii-official-flow-controls.json` and `required_procedures.json` are byte-unchanged (or content-hash equal) after the slice.
8. **Matrix non-perturbation:** `git status` at slice end shows changes only under the slice artifact dir + authorized shared tests; official matrix, frozen plan, and source protocol unmodified.

Evidence labels: items 1-2 are verified facts from frozen artifacts; items 3-8 are review findings/recommendations; uncertainty: none material — all five anti-pattern modes are absent from the current matrix (verified), so they are preventive guards, not remediations.
